Oryzon Genomics
ID: 5331454Oryzon Genomics is a clinical stage biopharmaceutical company.
6
Funding Rounds
$40.7m
Money raised
Recent Funding Rounds
Overview
Oryzon Genomics is a clinical stage biopharmaceutical company.
- Websites:
- Business model: B2B
- Headquarters: Barcelona
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ta**** Ma** |
|
- | |
| Ca**** Bu*** |
|
- |
Funding series
Funding Series Analysis
The company Oryzon Genomics has raised a total of $17.02m in funding over 6 rounds.
Key Insights:
- Oryzon Genomics Series B round: $17.02m
- Oryzon Genomics Grant (money), December 2016: $800k
- Oryzon Genomics Venture round, July 2019: $20m
- Oryzon Genomics Grant (money), May 2019: $1.5m
- Oryzon Genomics Venture round, December 2018: $1.1m
- Oryzon Genomics Grant (money), April 2017: $300k
Industries
Oryzon Genomics is active in the following industries: